Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319436 · ClinicalTrials.gov registry record · NA
Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers
A NA study of Maternal Substance Use and Child Abuse and Neglect, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT00319436 is a NA study of Maternal Substance Use and Child Abuse and Neglect that has completed, run by Yale University. The registered enrollment target is 47 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00319436, a NA study of Maternal Substance Use and Child Abuse and Neglect, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this Stage I therapy development study will be to manualize and test the preliminary efficacy of a parenting intervention for drug dependent mothers that aims to foster their ability to recognize children's emotional needs at different ages and their capacity to be emotionally available to their children.
Conditions Studied
Interventions
- BEHAVIORAL Mentalizing Therapy for Substance Using Mothers
- BEHAVIORAL Standard Parent Education for Substance Using Mothers
Study Locations (1)
Connecticut
- The APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00319436
The ClinicalTrials.gov registry entry for NCT00319436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Maternal Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Mentalizing Therapy for Substance Using Mothers is the first listed.
NCT00319436 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00319436 about?
NCT00319436 is a clinical study titled "Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers". The primary goal of this Stage I therapy development study will be to manualize and test the preliminary efficacy of a parenting intervention for drug dependent mothers that aims to foster their ability to recognize children's emotional needs at different ages and their capacity to be emotionally av...
What is the current status of trial NCT00319436?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2004-08. Estimated completion is 2009-03.
What conditions does trial NCT00319436 study?
This clinical trial studies the following conditions: Maternal Substance Use, Child Abuse and Neglect.
What interventions are being tested in trial NCT00319436?
The interventions under investigation include: Mentalizing Therapy for Substance Using Mothers (BEHAVIORAL), Standard Parent Education for Substance Using Mothers (BEHAVIORAL).
Who is sponsoring clinical trial NCT00319436?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00319436 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.